Fri, May 17, 2024
Thu, May 16, 2024
Wed, May 15, 2024

Justin Zelin Initiated (TCRX) at Strong Buy and Held Target at $12 on, May 16th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-12-on-may-16th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Justin Zelin of BTIG, Initiated "TScan Therapeutics, Inc." (TCRX) at Strong Buy and Held Target at $12 on, May 16th, 2024.

Justin has made no other calls on TCRX in the last 4 months.



There are 4 other peers that have a rating on TCRX. Out of the 4 peers that are also analyzing TCRX, 0 agree with Justin's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Justin


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $15 on, Tuesday, May 14th, 2024
  • Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $11 on, Monday, May 13th, 2024
  • David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $10 on, Tuesday, April 23rd, 2024
  • Peter Lawson of "Barclays" Maintained at Buy with Increased Target to $9 on, Thursday, March 7th, 2024

Publication Contributing Sources